SUMMARY The effects of the screening programme for cancer of the uterine cervix in Great Britain are disputed, and the subject has been underexplored. Accordingly, we have related routinely available data on screening effort in Scotland, Wales, and the 14 English Health Regions to various incidence and mortality outcome measures, from 1967 to the present day. Although such an approach is imperfect, the results support the belief that the screening programme has been largely unsuccessful.
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Carcinoma of the uterine cervix is a common disease worldwide and a major cause ofmortality.1 2In Great Britain, it is the eighth most commonly registered cancer in women and has claimed between two and three thousand lives per year since 1950 when mortality statistics showing it separately from other uterine cancer were first presented. In that time the trend in mortality has shown a slow, shallow decline.3 4 Nevertheless the disease attracts considerable interest from the point ofview ofprimary and secondary prevention. Thus its main aetiology is thought to lie in the transmission of a carcinogen between the partners during heterosexual intercourse,5 6and this may pose enormous problems for primary prevention.7 8In contrast, for many years it has been regarded as a disease whose mortality might be reduced through screening, despite its inadequately understood natural history.9 In many countries, considerable resources have been devoted to this effort,2 and the results of several case-control studies have indicated that screening protects against the development of the malignancy. 11'4 Yet in only a few places have time trends in the disease indicated that the anticipated reduction in incidence or mortality has been achieved. '5 The effects of the screening programme in Great Britain are debated. ' 49 otherwise have occurred.'7 The little research using controls that has been carried out in Great Britain has been largely confined to Scotland where the small population makes interpretation difficult, and the comparison was simply of the burden of disease in a relatively well and relatively poorly screened population.'8 Accordingly, we have adopted an approach similar to that previously used in Canada'9 and the USA20 in which we evaluate the effectiveness of the screening programme by relating screening effort in the 14 English Health Regions, Wales, and Scotland to the subsequent incidence and mortality from the disease. Secondly, the mean Regional smear rates for populations aged 15-64 over three time periods were ranked, and Spearman's correlation coefficients with change, percentage change, and mean level of agestandardised mortality and registration were calculated. The indices used were the mortality ratio (SMR), proportional mortality ratio (SPMR), registration ratio (SRR), and proportional registration ratio (SPRR). These were all calculated using average Great Britain event rates in ten-year age groups between 15 and 64 as standard (1963- 
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